Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Horizontal portrait of David Metcalfe

Cauda equina syndrome is caused when the nerves at the end of the spinal cord, collectively called the cauda equina, are compressed. These nerves supply the legs, bladder, anus and sexual organs, and can be permanently damaged if compressed for too long. Most patients with cauda equina syndrome require an emergency operation to take pressure off the nerves. 

Severe back pain can be a sign of cauda equina syndrome, and patients often present to the Emergency Departments with pain, but very few actually have the condition. There is, as yet, no particular pattern of symptoms that can rule out the diagnosis without an MRI scan, but with no MRI scanning available at night some patients end up waiting too long before getting a diagnosis.

David Metcalfe, Clinical Lecturer in Emergency Medicine at the University of Oxford said: “Cauda equina syndrome is a spinal emergency and this project will help design services to achieve the best possible outcomes for this group of patients.” 

Claire Thornber, Founder of the Cauda Equina Syndrome Association said, “We are reassured by these efforts to address the issues around Cauda Equina Syndrome diagnosis, management and rehabilitation as so many patients are being lost in a system without pathways. The Cauda Equina Syndrome Association are looking forward to helping this project ensure all patients can access the services they need when and where they need them”.

The £1.23M Cauda Equina Syndrome Early Recognition (CESER) study has four phases:

  • Analysis of data from previous studies to identify symptoms that predict which patients have the condition.
  • Recruitment of 2000 patients with suspected cauda equina syndrome who will be examined by a doctor and then undergo an MRI scan. This will determine which symptoms help identify patients with a final diagnosis of the condition.
  • All NHS hospitals will be asked how they manage patients who might have cauda equina syndrome to identify differences and find examples of best practice.
  • The study will involve a range of stakeholders who will review the evidence and help develop recommendations about the assessment and diagnosis of patients with suspected cauda equina syndrome. 

These studies will help provide high-quality care across the NHS for patients that might have cauda equina syndrome with a view to making healthcare more efficient (and so possibly cheaper) as well as reducing harm to patients. 

Funded by

National Institute for Health and Care Research logo

Similar stories

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.